A non-randomised cohort study to evaluate immunogenicity and reactogenicity of adult formulation diphtheria-tetanus-pertussis vaccine in healthy adult healthcare workers and researchers working with children: a comparison of those who have previously received a booster and those who are previously unvaccinated

Trial Profile

A non-randomised cohort study to evaluate immunogenicity and reactogenicity of adult formulation diphtheria-tetanus-pertussis vaccine in healthy adult healthcare workers and researchers working with children: a comparison of those who have previously received a booster and those who are previously unvaccinated

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs DTaP vaccine (Primary)
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jun 2017 Planned End Date changed from 1 Dec 2016 to 22 Feb 2018.
    • 21 Jun 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 05 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top